Journal of the American Society of Hypertension
Volume 1, Issue 3 , Pages 208-215 , May 2007

Endothelial perturbation: a link between non-dipping and retinopathy in type 2 diabetes?

  • Søren Tang Knudsen, MD, PhD

      Affiliations

    • Medical Department M (Diabetes & Endocrinology), Aarhus University Hospital, Aarhus, Denmark
    • Corresponding Author InformationCorresponding author: Søren Tang Knudsen, MD, PhD, Medical Department M (Diabetes & Endocrinology), Aarhus University Hospital, DK-8000 Aarhus C, Denmark. Tel: +45 8618 7002; fax: +45 8949 2010.
    • ,
  • Peter Jeppesen, MD, PhD

      Affiliations

    • Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Christian Alcaraz Frederiksen, MD

      Affiliations

    • Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Niels Holmark Andersen, MD, PhD

      Affiliations

    • Medical Department M (Diabetes & Endocrinology), Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Toke Bek, MD, DMSc

      Affiliations

    • Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Jørgen Ingerslev, MD, DMSc

      Affiliations

    • Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Carl Erik Mogensen, MD, DMSc

      Affiliations

    • Medical Department M (Diabetes & Endocrinology), Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Per Løgstrup Poulsen, MD, DMSc

      Affiliations

    • Medical Department M (Diabetes & Endocrinology), Aarhus University Hospital, Aarhus, Denmark

Received 30 December 2006 ,Accepted 21 February 2007.

References 

  1. O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet. 1988;2:397
  2. Staessen JA, Asmar R, De Buyzere M, Imai Y, Parati G, Shimada K, et al. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit. 2001;6:355–370
  3. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793–801
  4. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000;35:844–851
  5. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-hour blood pressure: the Ohasama Study. J Hypertens. 2002;20:2183–2189
  6. Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, et al. Associations between non-dipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens. 2003;16:434–438
  7. Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22:273–280
  8. Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, et al. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes. 1995;44:783–789
  9. Hansen KW, Sorensen K, Christensen PD, Pedersen EB, Christiansen JS, Mogensen CE. Night blood pressure: relation to organ lesions in microalbuminuric type 1 diabetic patients. Diabet Med. 1995;12:42–45
  10. Berrut G, Fabbri P, Bouhanick B, Lalanne P, Guilloteau G, Marre M, et al. Decrease of nocturnal blood pressure in type II diabetic subjects with microalbuminuria. Arch Mal Coeur Vaiss. 1996;89:1041–1044
  11. Nakano S, Ishii T, Kitazawa M, Kigoshi T, Uchida K, Morimoto S. Altered circadian blood pressure rhythm and progression of diabetic nephropathy in non-insulin dependent diabetes mellitus subjects: an average three year follow-up study. J Investig Med. 1996;44:247–253
  12. Mitchell TH, Nolan B, Henry M, Cronin C, Baker H, Greely G. Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure. Am J Med. 1997;102:531–535
  13. Poulsen PL, Bek T, Ebbehøj E, Hansen KW, Mogensen CE. 24-hour ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. Diabetologia. 1998;41:105–110
  14. Knudsen ST, Poulsen PL, Hansen KW, Ebbehoj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens. 2002;15:244–250
  15. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797–805
  16. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes. 1998;47:1501–1506
  17. Stolarz K, Staessen JA, O’Brien ET. Night-time blood pressure: dipping into the future?. J Hypertens. 2002;20:2131–2133
  18. Känel RY, Jain SM, Mills PJ, Nelesen RA, Adler KA, Hong S, et al. Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J Hypertens. 2004;22:2087–2093
  19. Lee KW, Blann AD, Lip GYH. High pulse pressure and non-dipping circadian blood pressure in patients with coronary artery disease: relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens. 2005;18:104–115
  20. Deckert T, Feldt Rasmussen B, Borch Johnsen K, Jensen T, Kofoed Enevoldsen A. Albuminuria reflects widespread vascular damage: the steno hypothesis. Diabetologia. 1989;32:219–226
  21. Jensen T, Bjerre Knudsen J, Feldt Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet. 1989;1:461–463
  22. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 1992;340:319–323
  23. Knobl P, Schernthaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, et al. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36:1045–1050
  24. Stehouwer CD, Fischer HR, van Kuijk AW, Polak BC, Donker AJ. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes. 1995;44:561–564
  25. Parving HH, Nielsen FS, Bang LE, Smidt UM, Svendsen TL, Chen JW, et al. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia. 1996;39:1590–1597
  26. Fioretto P, Stehouwer CD, Mauer M, Chiesura-Corona M, Brocco E, Carraro A, et al. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia. 1998;41:233–236
  27. Nielsen S, Schmitz A, Bacher T, Rehling M, Ingerslev J, Mogensen CE. Transcapillary escape rate and albuminuria in type 2 diabetes (Effects of short-term treatment with low-molecular weight heparin). Diabetologia. 1999;42:60–67
  28. Knudsen ST, Foss CH, Poulsen PL, Bek T, Ledet T, Mogensen CE, et al. E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathy. Am J Physiol Endocrinol Metab. 2003;284:E1–E6
  29. Schmitz A, Ingerslev J. Haemostatic measures in type 2 diabetic patients with microalbuminuria. Diabet Med. 1990;1990:521–525
  30. Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T. The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol. 2006;244:1255–1261
  31. Ingerslev J. A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest. 1987;47:143–149
  32. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 1995;346:1080–1084
  33. Palatini P, Parati G. Modulation of 24-hour blood pressure profiles: a new target for treatment?. J Hypertens. 2005;23:1799–1801
  34. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension. 2001;38:E28–E32
  35. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE. Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study. J Intern Med. 2003;254:147–158
  36. Hermida RC, Calvo C, Ayala DE, Fernandez JR, Covelo M, Mojon A, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–1922
  37. Hermida RC, Calvo C, Ayala DE, Lopez JE. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension. 2005;46:960–968

 Conflict of interest: none.This study was supported by The Sehested Hansen Foundation, Gårdejer af Stenløse Peder Laurits Petersens Legat, The Beckett Foundation, The Jochum Jensen Memorial Grant, The Velux Foundation, and The Danish Diabetes Association. The authors would like to thank Merete Møller and Kirsten Christiansen for their excellent technical assistance.

PII: S1933-1711(07)00060-5

doi: 10.1016/j.jash.2007.02.006

Journal of the American Society of Hypertension
Volume 1, Issue 3 , Pages 208-215 , May 2007

Article Tools

* Image Usage & Resolution